Bivatuzumab
- Generic Name
- Bivatuzumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 0A0Z1IJN86
- Background
Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6.
- Indication
Investigated for use/treatment in cancer/tumors (unspecified) and head and neck cancer.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath